We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+8.82%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.94B
AUM Growth
+$2.67B
Cap. Flow
+$2.4B
Cap. Flow %
40.37%
Top 10 Hldgs %
19.09%
Holding
6,103
New
843
Increased
2,477
Reduced
2,101
Closed
546

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$206M
2
MSFT icon
Microsoft
MSFT
+$179M
3
AMZN icon
Amazon
AMZN
+$114M
4
TSLA icon
Tesla
TSLA
+$84M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$59.8M

Sector Composition

Rank Sector Weight
1 Technology 20.95%
2 Financials 11.56%
3 Healthcare 11.43%
4 Consumer Discretionary 10.98%
5 Communication Services 8.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INVX
3276
Innovex International
INVX
$2.19B
$42K ﹤0.01%
1,287
-5,820
-82% -$200K
CHUY
3277
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
$42K ﹤0.01%
938
-498
-35% -$19.1K
EGRX
3278
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$42K ﹤0.01%
1,017
+829
+441% +$38.5K
AWH
3279
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$42K ﹤0.01%
413
-6
-1% -$659
CHS
3280
DELISTED
Chicos FAS, Inc.
CHS
$42K ﹤0.01%
12,891
-108,972
-89% -$287K
KLR
3281
DELISTED
Kaleyra, Inc.
KLR
$42K ﹤0.01%
+842
New +$43.2K
TTM
3282
DELISTED
Tata Motors Limited
TTM
$42K ﹤0.01%
1,981
-3,077
-61% -$62K
ARTNA icon
3283
Artesian Resources
ARTNA
$365M
$41K ﹤0.01%
1,033
-1,589
-61% -$62.1K
CLSD
3284
DELISTED
Clearside Biomedical
CLSD
$41K ﹤0.01%
1,111
+796
+253% +$40K
EMLC icon
3285
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.79B
$41K ﹤0.01%
1,324
+1,050
+383% +$33.7K
EQBK icon
3286
Equity Bancshares
EQBK
$1.07B
$41K ﹤0.01%
1,495
-880
-37% -$22.4K
GERN icon
3287
Geron
GERN
$930M
$41K ﹤0.01%
26,309
+4,404
+20% +$7.87K
IRIX icon
3288
IRIDEX
IRIX
$14.8M
$41K ﹤0.01%
6,146
+2,442
+66% +$14.1K
ITOS
3289
DELISTED
iTeos Therapeutics
ITOS
$41K ﹤0.01%
1,203
+458
+61% +$16.6K
LEGN icon
3290
Legend Biotech
LEGN
$3.91B
$41K ﹤0.01%
1,407
-5,292
-79% -$144K
LOCO icon
3291
El Pollo Loco
LOCO
$472M
$41K ﹤0.01%
2,534
-410
-14% -$7.83K
LQDA icon
3292
Liquidia Corp
LQDA
$6.75B
$41K ﹤0.01%
15,106
+9,372
+163% +$27.7K
NTST
3293
NETSTREIT Corp
NTST
$2.11B
$41K ﹤0.01%
2,189
+1,530
+232% +$27.3K
TTI icon
3294
TETRA Technologies
TTI
$1.26B
$41K ﹤0.01%
17,257
+7,879
+84% +$17K
UFCS icon
3295
United Fire Group
UFCS
$1.39B
$41K ﹤0.01%
1,176
+30
+3% +$946
SILV
3296
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
$41K ﹤0.01%
5,092
+1,259
+33% +$11.5K
AY
3297
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
$41K ﹤0.01%
+1,110
New +$43.7K
NWLI
3298
DELISTED
National Western Life Group, Inc. Class A
NWLI
$41K ﹤0.01%
165
-877
-84% -$188K
AMTI
3299
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$41K ﹤0.01%
939
-954
-50% -$46.4K
PCTI
3300
DELISTED
PCTEL, Inc. Common Stock
PCTI
$41K ﹤0.01%
5,904
+2,587
+78% +$19.8K

Similar funds

Tower Research Capital (TRC)'s Q1 2021 Portfolio in Review

As of Q1 2021, Tower Research Capital (TRC) held 6,103 positions worth $5.94B, up 82% from $3.27B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Tower Research Capital (TRC) deployed $2.4B of net new capital in Q1 2021, opening 843 new positions and adding to 2,477 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 262,344 shares worth $15.9M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 9.8% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $685M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2021 buy was iShares Russell 1000 Growth ETF: 262,344 shares worth $15.9M.
  • Tower Research Capital (TRC) added most to Apple in Q1 2021, an estimated $206M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $685M.
  • Tower Research Capital (TRC) fully exited ARK Genomic Revolution ETF in Q1 2021, selling an estimated $7.27M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 19% of its $5.94B portfolio in Q1 2021.
  • Tower Research Capital (TRC) opened 843 new positions and closed 546 in Q1 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 82% quarter-over-quarter to $5.94B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2021, filed 17 May 2021.